B2
This small molecule, known as B2 or Linazolamide intermediate B impurity 2, has been shown to induce protein aggregation in cellular models of Huntington's and Parkinson's disease. It serves as a research tool for studying neurodegenerative disease mechanisms in vitro, particularly related to pathological inclusion formation.
Product Specifications
CAS Number
115687-05-3
Product Name Alternative
Sirtuin, 5-[4- (4-Chlorobenzoyl) -1-piperazinyl]-8-nitroquinoline, B2, B-2, B 2, CPNQ, Huntington's diseases, HIF/HIFProlylHydroxylase, HIF/HIF ProlylHydroxylase, HIF Prolyl-Hydroxylase, HIF ProlylHydroxylase, HIF, Inhibitor, HIFProlylHydroxylase, Linazolamide intermediate B impurity 2, inhibit, Parkinson's diseases
Field of Research
Epigenetics & Chromatin, Metabolism Research, Molecular Biology
Purity
99.14% (May vary between batches)
Solubility
H2O:2 mg/mL (5.04 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:50 mg/mL (126 mM)
Smiles
[O-][N+] (=O) c1ccc (N2CCN (CC2) C (=O) c2ccc (Cl) cc2) c2cccnc12
Molecular Formula
C20H17ClN4O3
Molecular Weight
396.83
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
